GAITHERSBURG, Md., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an…
AndyJanuary 14, 2025
January 13, 2025 - By Ruxandra Draghia-Akli, MD, PhD, Executive Vice President, Head of R&D and Elaine O’Hara, Executive Vice President,…
AndyJanuary 14, 2025
Like his fellow Type 1 diabetics, Alec Smith took insulin every day to regulate his blood sugar. Costs to treat…
AndyJanuary 14, 2025
GAITHERSBURG, Md., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that the Biomedical Advanced Research and Development Authority (BARDA), part…
AndyJanuary 13, 2025
It’s Baltimore’s latest move toward becoming a tech hub Meredith Cohn - 1/11/2025 - It looks like a rolling suitcase, a mask and…
AndyJanuary 13, 2025
*NOTE: Solution Summary due: February 14, 2025The Big Question What if we could end the rare disease diagnostic odyssey? The…
AndyJanuary 13, 2025
FREDERICK, Md., Jan. 9, 2025 /PRNewswire/ -- Veralox Therapeutics, a clinical-stage biotechnology company developing a new class of therapies targeting the 12-lipoxygenase…
AndyJanuary 10, 2025
GERMANTOWN, Md., & VENLO, The Netherlands--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the U.S. regulatory clearance of…
AndyJanuary 10, 2025
BELTSVILLE, Md., Jan. 10, 2025 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel,…
AndyJanuary 10, 2025